AQST
Aquestive Therapeutics Inc
4.80$
+3.7%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2005 | 2006 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +120.9% | +44.9% | +9.5% | +101.4% | -9.6% | -19.9% | -1.4% | -7.9% | +0.6% | +76.6% | +58.2% | |
| – | +625.6% | +40.1% | +20.7% | +163.5% | -7.9% | -34.7% | +5.9% | -15.6% | +2.7% | +115.3% | +69.2% | |
| – | +1,045.3% | -39.6% | +88.7% | +248.7% | -18.6% | -35.5% | -11.9% | -2.7% | -12.5% | +199.7% | +69.4% | |
| – | – | -39.6% | +88.7% | +248.7% | -18.6% | -35.5% | -11.9% | -2.7% | -12.5% | +199.7% | +69.4% | |
| – | +283.5% | +1,310.3% | -42.9% | +4.9% | +102.6% | -47.0% | +74.3% | -61.2% | +80.1% | -13.3% | +141.9% | |
| – | -31.6% | +534.3% | +39.1% | +35.6% | -47.5% | -13.9% | +64.1% | +43.1% | +17.1% | -10.7% | +2.1% | |
| – | +12.4% | +76.7% | -11.0% | -9.3% | -20.3% | -29.3% | -26.5% | +56.3% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -12.4% | -81.7% | -16.7% | -19.7% | -25.0% | -33.3% | -50.0% | +2,713.7% | -10.9% | – | – | |
| – | -74.9% | +2,873.1% | +22.2% | +10.3% | +10.2% | +31.7% | +29.4% | +21.9% | -6.7% | -1.4% | +20.1% | |
| – | +6.6% | +490.8% | +42.1% | +114.7% | -43.7% | +13.7% | +4.1% | +80.0% | -53.7% | +3.0% | +152.4% | |
| – | – | – | -99.1% | +1,252.9% | – | – | -11.5% | +548.3% | -97.8% | +30.1% | +2,068.8% | |
| – | -11.5% | +505.7% | +44.6% | +112.9% | -39.9% | -42.2% | +17.3% | +19.6% | -10.3% | +15.2% | +190.3% | |
| – | – | – | +17.7% | -6.4% | +41.6% | -43.1% | +50.2% | -35.1% | -17.8% | +18.1% | -15.3% | |
| – | +441.5% | -169.6% | – | – | -160.7% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -18.4% | +3.6% | +22.3% | +32.7% | +13.2% | +28.0% | +25.7% | +41.6% | +40.6% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.